Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SkinHealth SystemsSKIN -6.39%47 EV-to-EBITDA is 9.65 as of Sep. 09, 2026, which is 11% above its 10-year median of 8.72. GuruFocus rates SKIN with a GF Score™ of 47/100 and a GF Value™ of $1.44 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,661 Consumer Packaged Goods companies, SkinHealth Systems ranks worse than 53.46% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, SkinHealth Systems's enterprise value is $250.8 Mil.
SkinHealth Systems's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was $26.0 Mil. Therefore, SkinHealth Systems's EV-to-EBITDA for today is 9.65.
The historical rank and industry rank for SkinHealth Systems's EV-to-EBITDA or its related term are showing as below:
SKIN'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -26.75 Med: 8.72 Max: 360.49
Current: 9.65
During the past 8 years, the highest EV-to-EBITDA of SkinHealth Systems was 360.49. The lowest was -26.75. And the median was 8.72.
SKIN's EV-to-EBITDA is ranked worse than 53.46% of 1661
companies
in the Consumer Packaged Goods industry
Industry Median: 9.22
vs SKIN: 9.65
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
SkinHealth Systems (NAS:SKIN) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
SkinHealth Systems's PE Ratio (TTM) for today is calculated as:
SkinHealth Systems's share price for today is $0.69.
SkinHealth Systems's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.220.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for SkinHealth Systems's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, SkinHealth Systems's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SkinHealth Systems EV-to-EBITDA vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, SkinHealth Systems's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where SkinHealth Systems's EV-to-EBITDA falls into.
SkinHealth Systems's current Enterprise Value is $250.8 Mil.
SkinHealth Systems's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $26.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SkinHealth Systems (SKIN) has a EV-to-EBITDA of 9.65 as of Sep. 09, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on SkinHealth Systems. This is 11% above median its historical median of 8.72. According to the industry distribution chart, SkinHealth Systems ranks #888 out of 1661 companies in the Consumer Packaged Goods industry, placing it in the top 53.5%.
Is SkinHealth Systems' EV-to-EBITDA too high?
SkinHealth Systems' current EV-to-EBITDA of 9.65 is 11% above median its 10-year median of 8.72. The Consumer Packaged Goods industry median EV-to-EBITDA is 9.22. SkinHealth Systems' value of 9.65 is 4.7% above this industry median. Based on the distribution chart, SkinHealth Systems ranks #888 out of 1661 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, SkinHealth Systems has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SkinHealth Systems' EV-to-EBITDA compare to SLSN and GROV?
According to the Consumer Packaged Goods industry distribution chart, SkinHealth Systems ranks #888 out of 1661 companies for EV-to-EBITDA. This places SkinHealth Systems in the lower half of its industry. The industry median EV-to-EBITDA is 9.22. SkinHealth Systems' value of 9.65 is 4.7% above this benchmark. While the company's 10-year median is 8.72 vs. the industry median of 9.22, SkinHealth Systems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Consumer Packaged Goods company?
The median EV-to-EBITDA among Consumer Packaged Goods companies is 9.22, based on 1,661 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SkinHealth Systems's current EV-to-EBITDA of 9.65 is 4.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on SkinHealth Systems. For the Consumer Packaged Goods industry, the median EV-to-EBITDA is 9.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SkinHealth Systems's current EV-to-EBITDA is 9.65, which is 11% above median its own 10-year median of 8.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SkinHealth Systems stock overvalued right now?
Based on GuruFocus' analysis, SkinHealth Systems (SKIN) is currently considered Possible Value Trap. The stock's GF Value™ is $1.44, compared to a current price of $0.69 — trading 52.1% below its estimated fair value. The current EV-to-EBITDA is 9.65, which is 11% above median its 10-year median of 8.72 and 4.7% above the Consumer Packaged Goods industry median of 9.22. SkinHealth Systems' overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For SkinHealth Systems (SKIN), the current EV-to-EBITDA is 9.65 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SkinHealth Systems (SKIN) Overvalued in 2026?
Based on GuruFocus' analysis, SkinHealth Systems stock appears to be undervalued.
The current stock price of $0.69 is trading 52.1% below its estimated GF Value™ of $1.44.
GuruFocus considers SkinHealth Systems to be Possible Value Trap.
Key valuation signals for SKIN:
EV-to-EBITDA: 9.65 (11% above median its 10-year median of 8.72)
GF Value™: $1.44 vs. price of $0.69 (52.1% below fair value)
Industry Position: 4.7% above the Consumer Packaged Goods median (#888 of 1661)
No single metric tells the full story. See the SKIN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SkinHealth Systems Inc is a world-wide medical aesthetics company delivering an integrated ecosystem of clinically validated solutions designed to help consumers achieve superior skin health and support the success of providers. Its brands are Hydrafacial and SkinStylus.
47GF Score
Get the complete analysis for SKIN
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SKIN has been successfully added to your 
